Definitive Contract W58P0522C0010

Award Date 1/13/22
Potential Completion Date 5/31/22
Potential Value $570M
Contracting Federal Agency
ACC Aberdeen Proving Ground
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
20
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency (DOD) awarded a $700,000 firm fixed price blanket purchase agreement call contract to Roche Diagnostics Corporation to provide COVID 19 tests and supplies. The contract supports the National Interest Action Code of Coronavirus COVID-19 and will deliver testing materials from Roche's location in Bethesda, Maryland to assist DOD in responding to the ongoing pandemic. The one year contract period from March 2020 through March 2021 aims to ensure DOD medical facilities have...
The Defense Health Agency awarded Roche Diagnostics Corporation a $500,000 firm fixed price blanket purchase agreement call contract to provide reagents and test kits for COVID-19 testing. The contract was awarded under the National Interest Action Code for coronavirus response and will be performed in Bethesda, Maryland through August 2021. As the prime contractor, Roche will support the Defense Health Agency's efforts to expand COVID-19 testing capacity. No subcontractors or set aside...
Roche Diagnostics Corporation was awarded a $244,108 firm fixed price blanket purchase agreement call contract by the Defense Health Agency to deliver COBAS SARS COVID REAGENT KITS. The contract supports the agency's efforts responding to the Coronavirus COVID-19 national interest and has a period of performance through March 15, 2022. Roche will provide the diagnostic test kits from its place of performance in Bethesda, Maryland to assist the Defense Health Agency in testing for COVID-19. No...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $1.35 billion definitive contract to Abbott Rapid DX North America LLC for COVID-19 antigen test kits. The contract calls for Abbott to provide over-the-counter COVID-19 antigen test kits for personnel use, as requested in a December 2021 special notice seeking information on the availability and sourcing of FDA Emergency Use Authorization or 510(k) cleared rapid antigen tests. Tests will be...
This is a firm fixed-price contract awarded by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation for the procurement of COVID-19 testing kits and reagents for the USAFSAM Epidemiology Laboratory. The contract, which has a ceiling value of $300,160.00, calls for the delivery of Roche's micro automated molecular testing platform to support the laboratory's COVID-19 testing capabilities. This award was made without the use...
This federal contract award, valued at $87,632.08, was issued by the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation. The contract is for the provision of COVID-19 testing kits and reagents for the USAFSAM Epidemiology Laboratory. It was awarded as a Blanket Purchase Agreement (BPA) call under Roche's existing General Services Administration (GSA) Schedule contract for critical laboratory analyzers and supplies. The contract has...
This federal contract awarded to Roche Diagnostics Corporation by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base provides COVID-19 testing equipment, kits, and reagents for the USAFSAM Epidemiology Laboratory. The $28,570.88 firm fixed-price contract was awarded on September 21, 2020 under a Blanket Purchase Agreement call order from the Critical Analyzers, Laboratory (FSS-66-III) Federal Supply Schedule. The contract has no set-aside designation...
This is a firm fixed-price contract awarded by the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, for the provision of COVID-19 testing kits and reagents for the USAFSAM Epidemiology Laboratory. The contract was awarded on March 21, 2021 with a completion date of March 23, 2021 and a ceiling value of $88,432.08. This award is part of a Blanket Purchase Agreement (BPA) under Roche's...
Roche Diagnostics Corporation was awarded a $103,000 firm fixed price purchase order by the Department of the Army Medical Command to supply anti SARS COV products. The place of performance is Fort Liberty, NC and the completion date is September 30, 2020. The award is associated with the national interest action code for coronavirus COVID-19 response efforts. Roche, a foreign owned for-profit manufacturer of medical devices and supplies, will deliver the requested anti viral testing systems and...
This federal contract award was made by the U.S. Air Force Life Cycle Management Center (AFLCMC) to Roche Diagnostics Corporation for the provision of COVID-19 testing equipment and supplies. The $31,034.94 contract is a call against a Blanket Purchase Agreement (BPA) established under the General Services Administration (GSA) Critical Analyzers, Laboratory (FSS-66-III) schedule. The contract is for the delivery of the ROCHE MICRO AUTOMATED MOLECULAR TESTING PLATFORM and associated test kits and...

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $569.5 million definitive contract to Roche Diagnostics Corporation. The contract is for COVID-19 antigen test kits to support the Department of Defense and Department of Health and Human Services in response to the coronavirus pandemic. The original solicitation sought information on the availability of over-the-counter COVID-19 rapid antigen tests that could be used by government personnel, including details on production capacity, manufacturing locations, inventory levels, packaging configurations, and monthly production capabilities through April 2022. The place of performance for Roche Diagnostics Corporation is in Castleton, Indiana. The contract has a period of performance from January 13, 2022 through May 31, 2022 and utilizes a firm fixed price contract type.

Generated 12/29/23, 5:06 PM